Biopharmaceutical company
S. Con. Res 8 -- Concurrent Resolution on the Budget For Fiscal Year 2014
H Con Res 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 15 through 2033
HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013
In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs, especially changes to ASP, physician payment and oncology matters S. Con. Res 8 -- Concurrent Resolution on the Budget For Fiscal Year 2014
H Con Res 25 -- Establishing the budget for the US Government for FY 2014 and setting forth appropriate budgetary levels for FY 15 through 2033
HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013
In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs FDA related matters including issues related to "biosimilar products," prescription drug "track and trace" and orphan drug products Implementation of the new health care reform law - PL 111-148, specifically with regard to those provisions impacting Medicare/Medicaid prescription drug coverage in the essential benefit pkg, and other matters
MMM - Medicare/Medicaid BUD - Budget/Appropriations PHA - Pharmacy HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
SLC HEALTH STRATEGIES, LLC
9710 Traville Gateway Drive, Number 157, Rockville, MD, 20850, US
SHARON COHEN SHARON COHEN SHARON COHEN SHARON COHEN